Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV

• Published in: BMC cancer Vol. 23; no. 1; pp. 1 - 830
• Main Authors: Chetty-Sebastian, Devamani, Assounga, Alain G
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 06-09-2023; BioMed Central; BMC
• Subjects: Adenomatous polyposis coli; Analysis; Antigen-presenting cells; Biopsy; Care and treatment; CD25 antigen; CD4 antigen; Cell-mediated cytotoxicity; Cervical cancer; Cloning; Comorbidity; Cytotoxicity; Deoxyribonucleic acid; Development and progression; DNA; Flow cytometry; Foxp3 protein; Genotypes; HIV; HIV (Viruses); HIV infection; HIV patients; Human immunodeficiency virus; Human papillomavirus; Immune response; Immunoregulation; Immunosuppression; Infection; Infections; Leukocytes (mononuclear); Lymphocytes; Lymphocytes T; Peripheral blood mononuclear cells; Regulatory T cells; Statistical analysis; T cells; Tumors; Women; Womens health; South Africa; United States > US
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-023-11345-9

Background Persistent high-risk Human papillomavirus (HR-HPV) infections are the main cause of cervical cancer. Cumulative evidence implicates regulatory T cells (Tregs) as a critical factor in the failure to eliminate HPV-induced cancers leading to their persistence and progression to cancer. Also, the WHO recognised cervical cancer as 100% attributable to persistent HR-HPV infection. The province of KwaZulu-Natal (KZN) in South Africa has a high prevalence of cervical cancer and HIV infection. Materials and methods We evaluated Treg frequency in dual infection of HR HPV and HIV coinfection using phenotypic markers, CD4, CD25 and intracellular Foxp3, in the peripheral blood of 51 cervical cancer and 46 non-cervical cancer participants and evaluated the effect of HIV on regulatory T cell proportion. Peripheral blood mononuclear cells were surface stained with a cocktail fluorescent labelled CD4 and CD25 and subsequently with APC anti-human FoxP3 (eBioscience). Flow cytometry was performed with FACS analysis. Statistical analysis of results was done using Instat 3 program (GraphpadR). Tregs results were expressed as median [+ or -] interquartile range (IQR). Associations of cervical cancer with demographic, clinical and laboratory variables were evaluated by univariate and multivariate logistic regression analysis using SPSS version 27 (IBM). Results Tregs frequency was significantly higher in individuals with cervical cancer (11.00 [+ or -] 19.79%) compared to controls (1.71 [+ or -] 8.91%) (p < 0.0001). HIV infection was associated with an increase in Tregs frequency. In controls a significant difference in Tregs frequency was noted between women living with HIV (6.00 [+ or -] 10.57%, n = 9) and those without HIV (1.30 [+ or -] 6.10%, n = 37), p = 0.0023. In multivariate logistic regression, Tregs frequency was significantly associated with cervical cancer after controlling for age, smoking, weight loss, presence of STI, HIV and HPV genotype. Discussion/Conclusion Higher Tregs frequency was significantly associated with cervical cancer highlighting the immunosuppressive role of Tregs in cervical cancer. Treg frequency was more strongly associated with cervical cancer than HIV infection. We provide baseline data for monitoring Treg frequencies in response to new preventive and therapeutic strategies in the management of cervical cancer. Keywords: Regulatory T cells, Cervical cancer, HIV, Human papillomavirus, Immunosuppression